North America: Largest market, powered by high drug consumption, strong regulatory frameworks, and advanced biotech manufacturing infrastructure. Asia Pacific: Fastest-growing, led by India's contract ...
Producing active pharmaceutical ingredients (API), raw materials of medicine, is urgent to save the country’s promising pharmaceuticals industry still heavily dependent on imports, industry insiders ...
Industry urges govt to tap idle API manufacturing capacity to avoid costly duplication: Shardul Nautiyal, Mumbai Monday, June 22, 2026, 08:00 Hrs [IST] Industry associations have ...
Almost half of all FDA warnings letters since early 2018 were sent to Indian and Chinese plants, according to a report. (FDA) China and India, which are the largest producers of APIs for the U.S. drug ...
Health experts and pharmaceutical industry leaders yesterday called for policy support and the removal of tariff and non-tariff barriers to boost local production of raw materials for drugs, aiming to ...
The Active Pharmaceutical Ingredients (API) Market plays a crucial role in the pharmaceutical industry, forming the backbone of drug development and production. APIs are the biologically active ...
In drug development, the active pharmaceutical ingredient (API) is the drug component that provides the health benefits. The purpose of adding APIs is to cause pharmacological activity or direct ...
Demand for highly potent APIs continues to rise. Highly potent APIs (HPAPIs) are an increasingly important segment of the API market. While there are many contract development and manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results